Recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas NCT07217171 Conditions Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +38 more Locations City of Hope — Duarte, California, United States USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States Yale University Cancer Center — New Haven, Connecticut, United States The Winship Cancer Institute Emory University — Atlanta, Georgia, United States View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 Conditions Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States University of South Alabama Mitchell Cancer Institute — Mobile, Alabama, United States Anchorage Associates in Radiation Medicine — Anchorage, Alaska, United States Anchorage Radiation Therapy Center — Anchorage, Alaska, United States View all 1007 locations View more locations Show fewer locations Loading locations... View Trial Details
